Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Medical Imaging Reagents Market by Class (Contrast Reagents, Optical Reagents, and Nuclear Reagents), Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, and Quantum Dots) and Application (Diagnostics, Drug Discovery & Development, and Educational Research): Global Opportunity Analysis and Industry Forecast, 2019–2027

A01339
Pages: 231
Oct 2020 | 7183 Views
 
Author(s) : Sanjivan Gill, Sushant Terdale , Onkar Sumant
Tables: 123
Charts: 45
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medical Imaging Reagents Market

Request Now !

Medical Imaging Reagents Market Overview:

The global medical imaging reagents market was valued at $11,698 million in 2019, and is projected to reach $17,329 million by 2027, registering a CAGR of 5.0% from 2019 to 2027. 

Medical imaging reagent is defined as substance administered to patients before medical imaging procedure. Furthermore, they are used to enhance contrast in images of the inside of the body obtained using X-rays, γ-rays, and radioactive particles. In addition, based on technology of medical imaging techniques, different types of medical imaging reagents are employed. For instance, there are different types of medical imaging reagents that include contrast reagents, optical reagents, and nuclear reagents. Moreover, these medical reagents are used in medical imaging, which is conducted for diagnosis of medical conditions, discovery, and development of new drugs and educational research.  

Medical-Imaging-Reagents-Market-2019-2027

Get more information on this report : Request Sample Pages

Rise in cases of chronic diseases such as cancer and cardiovascular diseases, surge in technological advancements, development in medical imaging reagents, and high unmet medical and diagnostic imaging procedure needs are key factors that fuel growth of the global medical imaging reagents market. For instance, cardiovascular diseases are one of the leading causes of deaths across the globe. Moreover, aged patients are at highest risk of suffering from chronic diseases; thus, rapid increase in geriatric population is expected to further drive the demand for medical imaging reagents. In addition, growth in demand for medical imaging reagents, owing to rise in number of cancer patients who need superior diagnostic imaging techniques, such as photoacoustic imaging technique and imaging reagents for improved diagnosis also contributes toward growth of the market. Moreover, rise in geriatric population, increase in expenditure on healthcare, and growth in demand for effective procedures and safe medication are expected to fuel the medical imaging reagents market growth. 

In addition, another major factor that boosts the market growth includes rise in awareness related to early disease diagnosis. For instance, early diagnosis of chronic diseases increase chances of successful treatment. Therefore, healthcare providers continuously emphasize on early diagnosis of clinical disorders, which includes use of medical imaging techniques that in turn involves use of medical imaging reagents.

Conversely, untapped emerging markets in developing countries are expected to provide remunerative opportunities for market players. For instance, healthcare systems in developing countries such as Brazil, India, and China have experienced significant increase in investments in healthcare and infrastructure, which leads to surge in demand for genetic testing in the region. However, lack of imaging reagent suppliers and strict government regulations are expected to hinder growth of the market.

Impact of COVID-19 on Global Medical Imaging Reagents Market

COVID-19 pandemic has affected the market adversely. For instance, after COVID-19 was declared as a pandemic by the WHO, countries worldwide adopted nationwide lockdowns to observe social distancing as a measure to contain the spread. This led to disruption, limitation, challenges, and changes in each sector of every industry. Similarly, the medical imaging reagents industry was also impacted by the pandemic. For instance, medical imaging reagents are used in medical imaging for diagnosis of clinical conditions. Thus, limited availability of medical care for conditions other than COVID-19 around the world has impacted the number of medical imaging procedures conducted worldwide in a negative manner. Furthermore, limited availability of healthcare staff across the world is another major factor, which has a negative effect on the medical imaging reagents market. In addition, medical imaging related to disease conditions that are not urgent and can be postponed such as in case of cancer has also impacted market in a negative way. 

Medical Imaging Reagents Market Segmentation  

The global medical imaging reagents market is segmented on the basis of class, technology, application, and region. By class, it is divided into contrast reagents, optical reagents, and nuclear reagents. The technology segment includes nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. By application, it is categorized into diagnostics, drug discovery & development, and educational research. Region wise, the medical imaging reagents market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Taiwan and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Medical Imaging Reagents Market
By Class

Your browser does not support the canvas element.

Nuclear reagents segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Segment Review

On the basis of class, the contrast reagents segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. Key factors such as increase in approvals for contrast reagents and rise in establishment of a number of public & private diagnostic centers and rise in prevalence of cardiovascular disease, increase in demand for contrast reagents, and advantages such as better image quality and detection of any disorder in the body boosts the medical imaging reagents market growth.

On the basis of technology, the market is classified into nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. The nanoparticles segment accounted for the maximum medical imaging reagents market share and was the fastest growing segment in 2019, and is anticipated to maintain its dominant position during the forecast period. This is attributed to rise in demand for nanoparticles in medical imaging technology, rise in use of nanoparticles in targeted cancer imaging, technological advancements in nanotechnology, and surge in support of governmental and non-governmental authorities to increase public enrollment associated with early disease diagnosis.    

Medical Imaging Reagents Market
By Technology

Your browser does not support the canvas element.

Nanoparticles segment held a dominant position in 2019 and will continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

North America accounted for the largest share of the global medical imaging reagents market size in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to rise in prevalence of cardiovascular & neurological diseases and cancer and growth in awareness related to medical imaging reagents. Moreover, rise in geriatric population, large number of target population with higher health awareness, and availability of trained medical professionals are other factors that fuel growth of the market. Asia-Pacific is expected to experience highest growth rate during the forecast period, majorly owing to increase in number of medical imaging procedures and surge in adoption of medical imaging reagents in advanced diagnostic imaging procedures. 

The global medical imaging reagents market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum medical imaging reagents market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Bayer AG, Bracco SpA, Cardinal Health, Eli Lilly and Company, General Electric Company (GE Healthcare), Lantheus Holdings, Inc., LI-COR Biosciences Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., and Thermo Fisher Scientific Inc.

Medical Imaging Reagents Market
By Geography

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 8.1% during 2019-2027.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global medical imaging reagents market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The medical imaging reagents market forecast is studied from 2019 to 2027. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the medical imaging reagents market.

Key Market Segments

By Class

  • Contrast Reagents
  • Optical Reagents
  • Nuclear Reagents

By Technology

  • Nanoparticles
  • Fluorescent Dyes & Probes
  • Radiopharmaceuticals
  • Fluorescent Proteins
  • Quantum Dots

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic diseases
3.5.1.2.Rise in awareness for early disease diagnosis
3.5.1.3.Surge in demand for diagnostic imaging procedures

3.5.2.Restraints

3.5.2.1.Shortage of supplies of imaging reagents
3.5.2.2.Lack of access in underdeveloped countries

3.5.3.Opportunities

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Covid-19 Impact analysis on medical imaging reagents market

CHAPTER 4:MEDICAL IMAGING REAGENTS MARKET, BY CLASS

4.1.Overview

4.1.1.Market size and forecast

4.2.Contrast reagents

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Optical reagents

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Nuclear reagents

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast

5.2.Nanoparticles

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Fluorescent dyes & probes

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Radiopharmaceuticals

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Fluorescent proteins

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

5.6.Quantum dots

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country

CHAPTER 6:MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Diagnostics

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Drug discovery & development

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Educational research

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:MEDICAL IMAGING REAGENTS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. medical imaging reagents market, by class
7.2.2.1.2.U.S. medical imaging reagents market, by technology
7.2.2.1.3.U.S. medical imaging reagents market, by application

7.2.2.2.Canada

7.2.2.2.1.Canada medical imaging reagents market, by class
7.2.2.2.2.Canada medical imaging reagents market, by technology
7.2.2.2.3.Canada medical imaging reagents market, by application

7.2.2.3.Mexico

7.2.2.3.1.Mexico medical imaging reagents market, by class
7.2.2.3.2.Mexico medical imaging reagents market, by technology
7.2.2.3.3.Mexico medical imaging reagents market, by application

7.2.3.North America market size and forecast, by class
7.2.4.North America market size and forecast, by technology
7.2.5.North America market size and forecast, by application

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany medical imaging reagents market, by class
7.3.2.1.2.Germany medical imaging reagents market, by technology
7.3.2.1.3.Germany medical imaging reagents market, by application

7.3.2.2.France

7.3.2.2.1.France medical imaging reagents market, by class
7.3.2.2.2.France medical imaging reagents market, by technology
7.3.2.2.3.France medical imaging reagents market, by application

7.3.2.3.UK

7.3.2.3.1.UK medical imaging reagents market, by class
7.3.2.3.2.UK medical imaging reagents market, by technology
7.3.2.3.3.UK medical imaging reagents market, by application

7.3.2.4.Italy

7.3.2.4.1.Italy medical imaging reagents market, by class
7.3.2.4.2.Italy medical imaging reagents market, by technology
7.3.2.4.3.Italy medical imaging reagents market, by application

7.3.2.5.Spain

7.3.2.5.1.Spain medical imaging reagents market, by class
7.3.2.5.2.Spain medical imaging reagents market, by technology
7.3.2.5.3.Spain medical imaging reagents market, by application

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe medical imaging reagents market, by class
7.3.2.6.2.Rest of Europe medical imaging reagents market, by technology
7.3.2.6.3.Rest of Europe medical imaging reagents market, by application

7.3.3.Europe market size and forecast, by class
7.3.4.Europe market size and forecast, by technology
7.3.5.Europe market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan medical imaging reagents market, by class
7.4.2.1.2.Japan medical imaging reagents market, by technology
7.4.2.1.3.Japan medical imaging reagents market, by application

7.4.2.2.China

7.4.2.2.1.China medical imaging reagents market, by class
7.4.2.2.2.China medical imaging reagents market, by technology
7.4.2.2.3.China medical imaging reagents market, by application

7.4.2.3.Australia

7.4.2.3.1.Australia medical imaging reagents market, by class
7.4.2.3.2.Australia medical imaging reagents market, by technology
7.4.2.3.3.Australia medical imaging reagents market, by application

7.4.2.4.India

7.4.2.4.1.India medical imaging reagents market, by class
7.4.2.4.2.India medical imaging reagents market, by technology
7.4.2.4.3.India medical imaging reagents market, by application

7.4.2.5.South Korea

7.4.2.5.1.South Korea medical imaging reagents market, by class
7.4.2.5.2.South Korea medical imaging reagents market, by technology
7.4.2.5.3.South Korea medical imaging reagents market, by application

7.4.2.6.Taiwan

7.4.2.6.1.Taiwan medical imaging reagents market, by class
7.4.2.6.2.Taiwan medical imaging reagents market, by technology
7.4.2.6.3.Taiwan medical imaging reagents market, by application

7.4.2.7.Rest of Asia-Pacific

7.4.2.7.1.Rest of Asia-Pacific medical imaging reagents market, by class
7.4.2.7.2.Rest of Asia-Pacific medical imaging reagents market, by technology
7.4.2.7.3.Rest of Asia-Pacific medical imaging reagents market, by application

7.4.3.Asia-Pacific market size and forecast, by class
7.4.4.Asia-Pacific market size and forecast, by technology
7.4.5.Asia-Pacific market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil medical imaging reagents market, by class
7.5.2.1.2.Brazil medical imaging reagents market, by technology
7.5.2.1.3.Brazil medical imaging reagents market, by application

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia medical imaging reagents market, by class
7.5.2.2.2.Saudi Arabia medical imaging reagents market, by technology
7.5.2.2.3.Saudi Arabia medical imaging reagents market, by application

7.5.2.3.South Africa

7.5.2.3.1.South Africa medical imaging reagents market, by class
7.5.2.3.2.South Africa medical imaging reagents market, by technology
7.5.2.3.3.South Africa medical imaging reagents market, by application

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA medical imaging reagents market, by class
7.5.2.4.2.Rest of LAMEA medical imaging reagents market, by technology
7.5.2.4.3.Rest of LAMEA medical imaging reagents market, by application

7.5.3.LAMEA market size and forecast, by class
7.5.4.LAMEA market size and forecast, by technology
7.5.5.LAMEA market size and forecast, by application

CHAPTER 8:COMPANY PROFILES

8.1.BAYER AG

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.BRACCO SPA

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.CARDINAL HEALTH

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.ELI LILLY AND COMPANY

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.LANTHEUS HOLDINGS, INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.LI-COR BIOSCIENCES INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio

8.8.MERCK KGAA (SIGMA-ALDRICH)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.PERKINELMER, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.THERMO FISHER SCIENTIFIC, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

LIST OF TABLES

TABLE 01.MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027 ($MILLION)
TABLE 02.CONTRAST REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.OPTICAL REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.NUCLEAR REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 06.NANOPARTICLES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.FLUORESCENT DYES AND PROBES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.RADIOPHARMACEUTICALS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.FLUORESCENT PROTEINS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.QUANTUM DOTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 11.MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.DIAGNOSTICS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.DRUG DISCOVERY & DEVELOPMENT MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.EDUCATIONAL RESEARCH MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.U.S. MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 18.U.S. MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 19.U.S. MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 20.CANADA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 21.CANADA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 22.CANADA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 23.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 24.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 25.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 26.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 27.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 28.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 29.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 30.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 31.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 32.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 33.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 34.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 35.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 36.UK MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 37.UK MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 38.UK MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 39.ITALY MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 40.ITALY MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 41.ITALY MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 42.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 43.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 44.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 45.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 46.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 47.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 48.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 49.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 50.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 51.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 52.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 53.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 54.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 55.CHINA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 56.CHINA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 57.CHINA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 58.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 59.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 60.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 61.INDIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 62.INDIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 63.INDIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 64.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 65.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 66.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 67.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 68.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 69.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 70.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 71.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 72.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 73.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 74.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 75.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 76.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 77.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 78.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 79.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 80.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 81.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 82.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 83.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 84.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 85.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 86.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 87.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 88.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 89.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 90.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 91.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 92.BAYER: COMPANY SNAPSHOT
TABLE 93.BAYER: OPERATING SEGMENTS
TABLE 94.BAYER: PRODUCT PORTFOLIO
TABLE 95.BAYER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.BRACCO: COMPANY SNAPSHOT
TABLE 97.BRACCO: OPERATING SEGMENT
TABLE 98.BRACCO: PRODUCT PORTFOLIO
TABLE 99.BRACCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 101.CARDINAL HEALTH: OPERATING SEGMENT
TABLE 102.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 103.LILLY: COMPANY SNAPSHOT
TABLE 104.LILLY: PRODUCT PORTFOLIO
TABLE 105.LILLY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.GE: COMPANY SNAPSHOT
TABLE 107.GE: OPERATING SEGMENT
TABLE 108.GE: PRODUCT PORTFOLIO
TABLE 109.GE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.LANTHEUS: COMPANY SNAPSHOT
TABLE 111.LANTHEUS: PRODUCT PORTFOLIO
TABLE 112.LANTHEUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113.LI-COR: COMPANY SNAPSHOT
TABLE 114.LI-COR.: PRODUCT PORTFOLIO
TABLE 115.MERCK: COMPANY SNAPSHOT
TABLE 116.MERCK: OPERATING SEGMENTS
TABLE 117.MERCK: PRODUCT PORTFOLIO
TABLE 118.PERKINELMER: COMPANY SNAPSHOT
TABLE 119.PERKINELMER: OPERATING SEGMENT
TABLE 120.PERKINELMER: PRODUCT PORTFOLIO
TABLE 121.THERMO FISHER: COMPANY SNAPSHOT
TABLE 122.THERMO FISHER.: OPERATING SEGMENT
TABLE 123.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.MEDICAL IMAGING REAGENTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2019
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF CONTRAST REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF OPTICAL REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF NUCLEAR REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF NANOPARTICLES MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF FLUORESCENT DYES AND PROBES MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF RADIOPHARMACEUTICALS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF FLUORESCENT PROTEINS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF QUANTUM DOTS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF DIAGNOSTICS MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF DRUG DISCOVERY & DEVELOPMENT MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF EDUCATIONAL RESEARCH MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.BAYER: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.BAYER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 26.BAYER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 27.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.CARDINAL HEALTH: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 30.LILLY: NET SALES, 2017–2019 ($MILLION)
FIGURE 31.LILLY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 32.GE: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.GE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.GE: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.LANTHEUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.LANTHEUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.PERKINELMER: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.PERKINELMER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 42.PERKINELMER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 43.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 45.THERMO FISHER: REVENUE SHARE BY REGION, 2019 (%)

 
 

Medical imaging reagents are chemicals that allow physicians to improve imaging of tissues, specific organs, diseases, and physiological functions. Medical imaging reagents are used in diagnostics, drug discovery & development, and educational research.

Increase in prevalence of lifestyle diseases, owing to sedentary lifestyle and rise in awareness programs for early detection of chronic diseases across the globe are expected to drive growth of the medical imaging reagents market. In addition, rise in demand for radiopharmaceuticals in in vivo trials, increase in use of quantum dots medical imaging technology in pre-clinical studies, and rise in advance imaging in the field of drug discovery propels the market growth. However, shortage of supplies of imaging reagents is expected to hinder the growth of the market.

In addition, North America is expected to remain dominant during the forecast period, owing to increase in demand for medical imaging reagents, rise in prevalence of chronic diseases, and presence of major key players along with R&D centers. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in patient awareness toward medical imaging procedures.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of medical imaging reagents market is $11,697.74 million in 2019.

A. The forecast period for medical imaging reagents market is 2019 to 2027

A. The market value of medical imaging reagents market in 2020 is $8890.28 million.

A. The base year is 2019 in medical imaging reagents market

A. Top companies such as, General Electric Company (GE Healthcare), PerkinElmer, Inc., Lantheus Holdings, Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, and Cardinal Health dominated the global medical imaging reagents market in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Nuclear imaging reagents segment is the most influencing segment as these reagents are employed in nuclear imaging. The fact that the use of nuclear imaging is on a rise rise due to surge in fatal disease such as cancer makes the segment msot influencing.

A. The major factor that fuels the growth of the global medical imaging reagents market includes rise in prevalence of chronic ailments such as cancer, cardiovascular diseases, stroke and others which require the use of medical imaging which in turn employee the use of medical imaging reagents thereby boosting the growth of market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 10.0%. This is due to rise in adoption of medical imaging reagents in the region and surge in awareness related to early screening of chronic diseases

A. Medical imaging reagents are defined as chemicals which are injected to a patient's body undergoing medical imaging. Some examples included Gadofosveset, a MRI based contrast agent.

A. Medical imaging reagents are chemicals used to visualize structures or organs, thus assisting physicians to better diagnose and detect diseases.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Medical Imaging Reagents Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers